Loading clinical trials...
Loading clinical trials...
This is a prospective, open label, single center, self-controlled clinical study to demonstrate the safety and efficacy of intradermal botulinum toxin in treating hypertrophic scarring.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Roy G. Geronemus, M.D.
Collaborators
NCT07336368 · Keloid Scars, Hypertrophic Scars
NCT07147166 · Gender Dysphoria, Mastectomy, and more
NCT03561376 · Surgical Incision, Surgery--Complications, and more
NCT06913257 · Hypertrophic Scar
NCT06487910 · Burns, Hypertrophic Scar
Laser & Skin Surgery Center of New York
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions